A modified anticancer drug can simultaneously target tumor sites and show whether or not it is working
Cancer drugs can be modified to specifically target tumor sites to help personalize cancer treatment. And while it is relatively easy to determine if the drugs have been delivered to the correct location, it is more difficult to monitor their therapeutic success. Now, a team led by Bin Liu from the A*A*STAR Institute of Materials Research and Engineering in Singapore, in collaboration with Ben Zhong Tang at Hong Kong University of Science and Technology, has developed an anticancer drug with an inbuilt mechanism that shows if it is working1.
Platinum-based drugs are effective against many cancers, killing cells by triggering cellular suicide, or apoptosis. These drugs can, however, have severe side effects. Nontoxic forms can be modified, as a type of prodrug, to convert to their toxic form only after entering the targeted tumor cells, so as not to harm noncancerous cells.
Liu and colleagues went one step further by modifying a platinum-based prodrug to not only target tumor cells effectively, but also show whether or not it was having the desired effect. According to Liu, this added feature could be crucial for improving cancer treatment.
“Early evaluation of a patient’s response to a specific cancer therapy is important in clinical applications because it can minimize the duration of ineffective courses,” explains Liu. “The effectiveness of cancer treatment is commonly evaluated using magnetic resonance imaging to measure the tumor size, but this is unsatisfactory as the change in size is not obvious at the early stages of therapy.”
In their new system, Liu and her team included an apoptosis sensor that is released when the prodrug converts to its toxic form inside the targeted tumor cells. The toxic form triggers cell apoptosis and activates an enzyme called caspase 3, which then cleaves the apoptosis sensor and causes it to fluoresce green. This provides a visual signal that the drug is killing the cells.
The Latest on: Anticancer drug
via Google News
The Latest on: Anticancer drug
- Consensus lacking on ‘value’ for new anticancer drugson December 8, 2021 at 1:42 pm
The high price tag of new anticancer drugs has fueled debate about the value of these treatments, given the marginal clinical benefit of some newly approved treatments. But that debate is complicated ...
- New method predicts drug response of cancer patientson December 8, 2021 at 9:40 am
Researchers from Delft University of Technology and the Netherlands Cancer Institute (NKI) have developed an algorithm to predict patient response to anti-cancer drugs. This allows us to identify more ...
- An Overview of Cancer Spreading During Chemotherapyon December 7, 2021 at 8:29 pm
Chemotherapy is one of the most effective cancer treatments, but sometimes tumors can grow and cancer can spread during treatment.
- Protein variant identified that renders chemotherapy ineffective in gastric canceron December 6, 2021 at 8:06 am
A new protein variant underlies the ability of gastric cancers to resist an otherwise effective family of chemotherapy drugs, according to a study by a multidisciplinary team at Weill Cornell Medicine ...
- North America is Projected to Contribute a Market Share of 42% to the Global Anticancer Drugs Market – Fact.MR Studyon December 6, 2021 at 12:00 am
Pages Anticancer Drugs Market Survey by Fact MR, A Leading Business and Competitive Intelligence ProviderAccording to Fact MR’s recent market research, sales of Anticancer Drugs to swell at propelled ...
- HEALTH NOTES: Microscopic robot 'fish' could soon be used to deliver chemotherapy drugs directly into the tumours of cancer patientson December 4, 2021 at 2:01 pm
The robots, one-hundredth of a millimetre in size, were made my Chinese scientists using a special 3D printing technique, from a gel that changes shape when exposed to different pH levels.
- Drug in RA Trials Boosts Pancreatic Cancer Vulnerability to Chemoon December 2, 2021 at 4:00 am
Compared with chemotherapy alone, ATI-450 plus chemotherapy significantly reduced tumor size in mouse models, and increased survival by nearly 50%.
- Researchers identify new drug that makes pancreatic cancer cells more vulnerable to chemotherapyon December 1, 2021 at 3:55 pm
Researchers at Washington University School of Medicine in St. Louis have identified a drug compound that makes pancreatic cancer cells more vulnerable to chemotherapy.
- Anticancer Drug Market 2021 Top manufacturers Records are Roche,Celgene,Pfizer,Bristol-Myers Squibb,Novartis, Share & Trends Analysis 2025on November 26, 2021 at 8:11 pm
Anticancer Drug Market “ Size, Status and Market Insights 2021, ,Anticancer Drug Market By Type (Targeted Drugs,Cytotoxic Drugs,Hormonal Drugs,,), By Application ( Immunotherapy,Targeted ...
via Bing News